NYSE$CI
Cigna Group · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
Reported strong first quarter results reflecting growth across its diversified portfolio of businesses.
The Cigna Group reported strong first quarter 2024 results driven by the performance of Evernorth and Cigna Healthcare. The company increased its outlook for full-year earnings.
- Shareholders’ net loss for first quarter 2024 was $0.3 billion, or $0.97 per share, including a non-cash after-tax investment loss of $1.8 billion, or $6.31 per share, related to the impairment of VillageMD equity securities.
- Adjusted income from operations for first quarter 2024 was $1.9 billion, or $6.47 per share.
- The sale of our Medicare businesses to HCSC remains on track with the expiration of the waiting period under the Hart-Scott Rodino Act having occurred on April 17.
- The transaction is expected to close in the first quarter of 2025.
Headline financials
Revenue & EPS history
Cigna · Revenue · Quarterly
$57.3B
Forward guidance
The Cigna Group's outlook for full year 2024 adjusted revenues is at least $235.0 billion. The Cigna Group’s outlook for full year 2024 consolidated adjusted income from operations is at least $8.065 billion, or at least $28.40 per share. This outlook includes the impact of expected future share repurchases and anticipated 2024 dividends.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2024
-0.9%
Avg return
Earnings day
-1.1%
Avg return
5 days after
-0.4%
Avg return
30 days after
48%
31 / 65 earnings
Positive
+8.6%
Q1 2023
Best reaction
-17.4%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.5% | -5.7% | -5.2% | |
| Q4 2025 | -0.6% | -5.7% | -5.2% | |
| Q3 2025 | -17.4% | -11.5% | -7.3% | |
| Q2 2025 | -10.2% | -9.1% | +1.0% | |
| Q1 2025 | -0.5% | -0.2% | -5.5% | |
| Q4 2024 | -6.7% | -3.9% | +1.8% | |
| Q3 2024 | +1.2% | +1.8% | +8.0% | |
| Q2 2024 | -3.3% | -5.6% | +3.8% | |
| Q1 2024 | -4.4% | -2.9% | -3.5% | |
| Q4 2023 | +4.5% | +7.6% | +8.3% | |
| Q3 2023 | +0.4% | -4.6% | -13.1% | |
| Q2 2023 | -4.3% | -2.4% | -7.6% | |
| Q1 2023 | +8.6% | +8.1% | +5.5% | |
| Q4 2022 | -4.3% | -3.8% | -4.8% | |
| Q3 2022 | +0.4% | +2.1% | +2.0% | |
| Q2 2022 | +3.7% | +4.9% | +5.9% | |
| Q1 2022 | +4.4% | +1.9% | -0.7% | |
| Q4 2021 | -3.8% | +0.8% | +5.0% | |
| Q3 2021 | -1.9% | -0.9% | -8.4% | |
| Q2 2021 | -9.6% | -8.9% | -6.3% | |
| Q1 2021 | +3.9% | +0.7% | -1.6% | |
| Q4 2020 | -7.3% | -3.8% | +5.1% | |
| Q3 2020 | -4.3% | +4.5% | +3.3% | |
| Q2 2020 | -5.0% | -4.6% | -0.4% | |
| Q1 2020 | -4.5% | -2.8% | +0.7% | |
| Q4 2019 | +1.2% | +4.2% | -5.3% | |
| Q3 2019 | +1.7% | +3.1% | +13.3% | |
| Q2 2019 | -3.1% | -3.6% | -9.4% | |
| Q1 2019 | -5.7% | -4.2% | -8.6% | |
| Q4 2018 | -3.9% | -6.2% | -10.8% | |
| Q3 2018 | -0.3% | +0.2% | +4.5% | |
| Q2 2018 | +3.5% | +2.9% | +3.0% | |
| Q1 2018 | -0.7% | -1.0% | -0.9% | |
| Q4 2017 | -1.9% | -5.2% | -7.3% | |
| Q3 2017 | +2.1% | +3.9% | +5.3% | |
| Q2 2017 | -0.0% | +1.2% | +4.0% | |
| Q1 2017 | +3.2% | +3.9% | +4.9% | |
| Q4 2016 | +1.1% | +0.2% | +2.9% | |
| Q3 2016 | +3.2% | +9.3% | +13.2% | |
| Q2 2016 | -6.8% | -8.4% | -6.1% | |
| Q1 2016 | -2.6% | — | — | |
| Q4 2015 | +0.4% | — | — | |
| Q3 2015 | +0.4% | — | — | |
| Q2 2015 | -0.9% | — | — | |
| Q1 2015 | -0.9% | — | — | |
| Q4 2014 | +1.5% | — | — | |
| Q3 2014 | +5.9% | — | — | |
| Q2 2014 | -2.9% | — | — | |
| Q1 2014 | +3.3% | — | — | |
| Q4 2013 | -10.1% | — | — | |
| Q3 2013 | +5.0% | — | — | |
| Q2 2013 | -0.7% | — | — | |
| Q1 2013 | +2.7% | — | — | |
| Q4 2012 | +3.8% | — | — | |
| Q3 2012 | +4.1% | — | — | |
| Q2 2012 | +4.6% | — | — | |
| Q1 2012 | -2.8% | — | — | |
| Q4 2011 | +2.9% | — | — | |
| Q3 2011 | -6.0% | — | — | |
| Q2 2011 | +1.8% | — | — | |
| Q1 2011 | +2.4% | — | — | |
| Q4 2010 | +4.3% | — | — | |
| Q3 2010 | +2.0% | — | — | |
| Q2 2010 | -6.3% | — | — | |
| Q1 2010 | +1.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro